HIV drug resistance and immune recovery study
Part of Immune system & allergy, Infections clinical trials.
This study looks at whether certain genetic changes in the HIV virus (called drug resistance mutations) affect how well your immune system recovers after you start HIV treatment. It could help doctors understand why some people on HIV therapy have better immune recovery than others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be living with HIV.
- You must be at least 18 years old.
- You must not have taken any HIV medications before (you're starting treatment for the first time).
- After about 6 months of HIV treatment, your virus should be suppressed (very low or undetectable).
- You must have had a blood test before starting treatment that checked your HIV for drug resistance (how well the virus responds to medications).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how active the immune system is and how large the “hidden” HIV reservoir is in people on two different HIV treatment types. It may help researchers understand whether staying on a tenofovir-containing regimen leads to better control of HIV hiding in the body.
This study looks at how HIV continues to multiply (or stays suppressed) while you are taking antiretroviral therapy, using blood samples. It may help researchers better understand what HIV is doing during treatment and why some people experience changes like viral rebound.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
This study looks closely at how your immune system and HIV infection markers change right after a new HIV diagnosis. It may help doctors understand the earliest stages of HIV and improve how infections are measured and followed over time.
This study tests new treatments to help people with HIV who have low CD4 counts despite antiretroviral therapy. It aims to improve immune function and reduce the risk of infections.
This study looks at how certain immune cells (NK cells) behave in people who have been on HIV treatment for a long time. It aims to understand why some people's immune systems respond differently, which could help improve future treatments.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.